APR 02, 2015 10:06 AM PDT

Versatile Smart Phone Diagnosis?

WRITTEN BY: Judy O'Rourke
Similar to the way glucometers and pregnancy tests have revolutionized in-home diagnostic testing, researchers from Florida Atlantic University (FAU) and collaborators from Harvard Medical School and the Stanford School of Medicine have identified a new biosensing platform that could be used to remotely detect and decide on treatment options for HIV, E. coli, Staphylococcus aureus, and other bacteria.

Using a drop of blood from a fingerprick, this biosensing platform provides clinically relevant specificity, sensitivity, and detection of pathogens from whole blood and plasma, the researchers say.
Thin, lightweight, flexible materials developed by researchers at Florida Atlantic University, Stanford, and Harvard, integrate cellulose paper and flexible polyester films as new diagnostic tools to detect bioagents in whole blood, serum, and peritoneal fluid.
"There is a dire need for robust, portable, disposable, and inexpensive biosensing platforms for clinical care, especially in developing countries with limited resources," says Waseem Asghar, PhD, assistant professor of electrical engineering, College of Engineering and Computer Science, FAU, co-first author on the study. "Existing paper and flexible material-based platforms use colorimetric, fluorometric, and electrochemical approaches that require complex labeling steps to amplify their signal, are very costly to fabricate, and also require expensive equipment and infrastructure."

In a recent article, the researchers address the limitations of available paper and flexible material-based platforms and discuss how they have integrated cellulose paper and flexible polyester films as new diagnostic tools to detect bioagents in whole blood, serum, and peritoneal fluid. They employed three different paper and flexible material-based platforms incorporated with electrical and optical sensing modalities, and demonstrate how these new materials can be widely applied to a variety of settings including medical diagnostic and biology laboratories.

Thin, lightweight, and flexible materials developed by the team can be fabricated and operated without the need for costly infrastructure and skilled personnel, potentially helping to solve real-world healthcare problems for developed and developing countries.

Using this technology, they have also developed a phone app that could detect bacteria and disease in the blood using images from a cellphone that could easily be analyzed from anywhere in the world.

This methodology offers a new, rapid, and cost-effective way to diagnose diseases and monitor treatment in point-of-care settings, and these new platforms are able to isolate and detect multiple biotargets selectively, sensitively, and repeatedly from diverse biological mediums using antibodies.

"The future of diagnostics and health monitoring will have potentially cell-phone based or portable readers sipping saliva or blood and continuously monitoring human health, taking it way beyond where we are with counting steps today," says Utkan Demirci, PhD, Stanford School of Medicine, who is the corresponding author.

Demirci notes that these platforms could potentially be adapted and tailored to detect other pathogens and biotargets with well-known biomarkers.

"Our paper microchip technologies can potentially have a significant impact on infectious diseases management in low- and middle-income countries where there is limited laboratory infrastructure," says Hadi Shafiee, PhD, instructor in medicine, Division of Biomedical Engineering, Brigham and Women's Hospital, Harvard Medical School.

The article is "Paper and Flexible Substrates as Materials for Biosensing Platforms to Detect Multiple Biotargets," published in Nature Scientific Reports.

[Source: Florida Atlantic University]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
JAN 04, 2021
Cell & Molecular Biology
Good Results From Trial of CAR T Cell Therapy for Non-Hodgkin Lymphoma
JAN 04, 2021
Good Results From Trial of CAR T Cell Therapy for Non-Hodgkin Lymphoma
Researchers have reported positive results from a phase 2 clinical trial of a CAR T cell therapy called axicabtagene cil ...
JAN 04, 2021
Cannabis Sciences
How Does Cannabis Affect the Liver?
JAN 04, 2021
How Does Cannabis Affect the Liver?
As research on cannabis emerges, what we know about how it interacts with the liver is becoming more and more complex. A ...
JAN 20, 2021
Immunology
Gut Bacteria's Poison Arrows Exposed
JAN 20, 2021
Gut Bacteria's Poison Arrows Exposed
Bacteria armed with toxin bombs and excruciating abdominal pains caused by raging inflammation in the gut. While the cau ...
JAN 19, 2021
Clinical & Molecular DX
Fathers' Sperm Linked to Autism in Offspring
JAN 19, 2021
Fathers' Sperm Linked to Autism in Offspring
Researchers at Washington State University have uncovered a genetic link between fathers and children with autism spectr ...
JAN 19, 2021
Cardiology
Risk of Atrial Fibrillation Raised by Daily Alcoholic Drink
JAN 19, 2021
Risk of Atrial Fibrillation Raised by Daily Alcoholic Drink
Some studies have suggested that moderate alcohol intake is linked to a lower risk of death from heart disease. But that ...
JAN 24, 2021
Microbiology
Cholesterol Enables SARS-CoV-2 to Invade & Create 'Mega-Cells'
JAN 24, 2021
Cholesterol Enables SARS-CoV-2 to Invade & Create 'Mega-Cells'
To cause the COVID-19 illness, the SARS-CoV-2 virus first has to get into cells. To do so, it uses something called a sp ...
Loading Comments...